Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Fumonisin Monoclonal Antibody (2C7)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA549616

Catalog No. PIMA549616


Only null left
Add to Cart

Description

Description

Antibody tested in indirect ELISA.

The fumonisins are a group of myco- toxins produced primarily by Fusarium verticillioides and Fusarium proliferatum. Maize is the most commonly contaminated crop. Fusarium verticillioides and fumonisins are found worldwide. The primary health concerns associated with fumonisins are acute toxic effects in horses and swine and carcinogenic properties. Fumonisins are carcinogenic to laboratory animals, and, in humans, consumption of fumonisin- contaminated maize is associated with higher rates of esophageal cancer and neural tube birth defects. Fumonisins were first characterized in the late 1980s, as a result of studies into the causes of esophageal cancer in Africa, coupled with outbreaks of equine leuko- encephalomalacia and porcine pulmonary edema in the U.S.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Fumonisin
Monoclonal
4.3 mg/mL
PBS with 0.09% sodium azide; pH 7.4
Conjugate of FB hapten and KLH.
200 μg
Primary
-20°C, Avoid Freeze/Thaw Cycles
Liquid
ELISA, Immunohistochemistry, Lateral Flow, SDS-Page
2C7
Unconjugated
Mouse
Protein G
RUO
Fungi
Antibody
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.